Description
A naturally occurring sphingolipid; levels are elevated in the prefrontal cortex and cerebellum in a rat model of STZ-induced diabetes, as well as in the liver in mouse models of Niemann-Pick type C1 disease; plasma are decreased in patients with prostate cancer; has been used in model membranes with POPC and cholesterol in the study of lipid raft dynamics and membrane organization
Formal name: 4-hydroxy-7S-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-3,5-dioxa-8-aza-4-phosphatetracosan-1-aminium, 4-oxide, inner salt
Synonyms: N-Palmitoyl-D-erythro-Sphingosylphosphorylcholine|Palmitoyl Sphingomyelin|SM(d18:1/16:0)|Sphingomyelin (d18:1/16:0)
Molecular weight: 703
CAS: 6254-89-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cancer||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience